| 英文别名 |
Naltrexone hydrochloride;17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-onehydroch;17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-onhydr;17-(cyclopropylmethyl)-4,5-alpha-oxy-3,14-dihydoxy-morphinan-6-onhydrochlo;17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-morphinan-6-onhydrochlor;en1639a;n-cyclopropylmethyl-noroxymorphonehydrochloride;nih8503;N-CYCLOPROPYLMETHYL-14-HYDROXYDI-HYDROMORPHINONE HYDROCHLORIDE;Naltrexone HCl;Naltrexone (Hydrochloride);Naltrexone Hydrochlo;(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one hydrochloride;Nalmefene Impurity C;(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride;ReVia;Depade;Nalorex;Antaxone;Ccris 1168;(5-alpha)-id;Einecs 240-723-0;HIC-A90670115;Trexan;En 1639A;NIH 8503;Nemexin;N-Cyclopropylmethyl-noroxymorphone hydrochloride;MLS000069607;Naltrexone hydrochloride [USP];Z6375YW9SF;NALTREXONE-HCl;SMR0;NALTREXONE HYDROCHLORIDE (MART.);Naltrexone Hcl;CS-0763;NALTREXONE HYDROCHLORIDE [MI];NALTREXONE HYDROCHLORIDE (USP MONOGRAPH);Q27096434;BN164635;(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride;ReVia (TN);NALTREXONE HYDROCHLORIDE [GREEN BOOK];UNII-Z6375YW9SF;XR-NTX;(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one hydrochloride;EINECS 240-723-0;Opera_ID_1828;CHEBI:134687;(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride;17-(Cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride;HY-76710;NS00085559;(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0,.0,.0,octadeca-7(18),8,10-trien-14-one hydrochloride;s2103;NALTREXONE HYDROCHLORIDE [EP MONOGRAPH];Naltrexone Hydrochloride 1.0 mg/ml in Methanol (as free base);CCG-268383;Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride, (5alpha)-;Naltrexone hydrochloride (USP);CYTO-205;(5alpha,17R)-17-(cyclopropylmethyl)-3,14-dihydroxy-6-oxo-4,5-epoxymorphinan-17-ium chloride;D02095;MLS001076516;EMBEDA COMPONENT NALTREXONE HYDROCHLORIDE;PTI-901;EN300-123642;SW196619-3;17-Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride;DTXCID101365810;Naltrexone hydrochloride, European Pharmacopoeia (EP) Reference Standard;N-Cyclopropylmethylnoroxymorphone hydrochloride;HS-0003;Prestwick_348;Naltrexone.HCl, 1mg/ml in Methanol (as free base);CHEMBL1201149;16676-29-2;MLS002695940;DTXSID50937236;SMR000058767;(5a)-17-(Cyclopropyl-methyl-d3)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride;NALTREXONE HYDROCHLORIDE [VANDF];Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-oxy-3,14-dihydoxy-, hydr... |